The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

Lung function trajectories for FEV1 and FVC increase rapidly in children until the mid-teens, then peak at age 20 in females and 23 years in males.

Frailty was a significant predictor of severe outcomes and hospitalization characteristics in older adults hospitalized with RSV infection.

Dupilumab in patients with diffuse type 2 CRSwNP had beneficial changes in nasal passage microbiota but did not alter gastrointestinal microbiota.

The CDC confirmed a nationwide uptick in COVID-19 cases, with increases seen in 25 states, suggesting a summer spike.

RFK Jr cancelled a meeting of the US Preventive Services Task Force, potentially interfering with their ability to make recommendations.

US funding cuts to global HIV prevention programs are estimated to cause 4 million deaths and 6 million cases of HIV.

Spikevax has been fully approved for children ages 6 months through 11 years with high-risk conditions. HealthDay News — Moderna’s COVID-19 vaccine has received full approval from the U.S. Food and ...

Influenza significantly impacted adults aged 50 to 64 years and younger adults with chronic conditions, but risk can be reduced with RIV.

Use of a pMDI with a holding chamber is noninferior to nebulization for delivering salbutamol in children with asthma exacerbations.

PRISm may be a precursor to COPD regardless of an individual’s smoking status, although smokers have faster lung function decline.

Treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis are under review.